O
Ossiam Portfolio holdings
AUM
$8.89B
1-Year Return
27.03%
This Quarter Return
+6.09%
1 Year Return
+27.03%
3 Year Return
+125.2%
5 Year Return
+180.05%
10 Year Return
–
AUM
$1.28B
AUM Growth
+$72.9M
(+6%)
Cap. Flow
+$30.6M
Cap. Flow
% of AUM
2.39%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
503
New
234
Increased
125
Reduced
97
Closed
26
Top Buys
| 1 |
Coca-Cola
KO
|
$56.9M |
| 2 |
Citigroup
C
|
$56.4M |
| 3 |
McDonald's
MCD
|
$52.1M |
| 4 |
Procter & Gamble
PG
|
$43.9M |
| 5 |
Texas Instruments
TXN
|
$34.6M |
Top Sells
| 1 |
Consolidated Edison
ED
|
$59.5M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$42.1M |
| 3 |
Honeywell
HON
|
$41.8M |
| 4 |
Chevron
CVX
|
$41M |
| 5 |
Exxon Mobil
XOM
|
$37.3M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Consumer Staples | 14.68% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Digital Realty Trust
DLR
$55.7B
| $63K | ﹤0.01% |
+539
| New | +$63K |
|
402
Lumen
LUMN
$4.87B
| $63K | ﹤0.01% |
+5,389
| New | +$63K |
|
403
Illumina
ILMN
$15.7B
| $62K | ﹤0.01% |
+174
| New | +$62K |
|
404
Synchrony
SYF
$28.1B
| $61K | ﹤0.01% |
+1,760
| New | +$61K |
|
405
Brighthouse Financial
BHF
$2.48B
| $60K | ﹤0.01% |
+1,637
| New | +$60K |
|
406
Intuitive Surgical
ISRG
$167B
| $60K | ﹤0.01% |
+345
| New | +$60K |
|
407
MSCI
MSCI
$42.9B
| $59K | ﹤0.01% |
+248
| New | +$59K |
|
408
Ameriprise Financial
AMP
$46.1B
| $57K | ﹤0.01% |
+396
| New | +$57K |
|
409
Vertex Pharmaceuticals
VRTX
$102B
| $57K | ﹤0.01% |
310
-17,472
| -98% | -$3.21M |
|
410
Brown & Brown
BRO
$31.3B
| $56K | ﹤0.01% |
+1,682
| New | +$56K |
|
411
Danaher
DHR
$143B
| $56K | ﹤0.01% |
+443
| New | +$56K |
|
412
KeyCorp
KEY
$20.8B
| $56K | ﹤0.01% |
+3,134
| New | +$56K |
|
413
Phillips 66
PSX
$53.2B
| $56K | ﹤0.01% |
602
| – | – |
|
414
Zoetis
ZTS
$67.9B
| $56K | ﹤0.01% |
+491
| New | +$56K |
|
|
CERN
415
DELISTED
Cerner Corp
CERN
| $55K | ﹤0.01% |
+752
| New | +$55K |
|
416
Delta Air Lines
DAL
$39.9B
| $55K | ﹤0.01% |
973
| – | – |
|
417
Idexx Laboratories
IDXX
$51.4B
| $54K | ﹤0.01% |
+195
| New | +$54K |
|
418
ResMed
RMD
$40.6B
| $54K | ﹤0.01% |
+439
| New | +$54K |
|
419
State Street
STT
$32B
| $54K | ﹤0.01% |
964
-4,668
| -83% | -$261K |
|
420
Everest Group
EG
$14.3B
| $53K | ﹤0.01% |
+215
| New | +$53K |
|
421
Boston Scientific
BSX
$159B
| $52K | ﹤0.01% |
+1,208
| New | +$52K |
|
|
Y
422
DELISTED
Alleghany Corporation
Y
| $52K | ﹤0.01% |
+77
| New | +$52K |
|
423
Becton Dickinson
BDX
$55.1B
| $49K | ﹤0.01% |
201
-283
| -58% | -$69K |
|
424
Edwards Lifesciences
EW
$47.5B
| $49K | ﹤0.01% |
798
-7,062
| -90% | -$434K |
|
425
Lamar Advertising Co
LAMR
$13B
| $49K | ﹤0.01% |
+601
| New | +$49K |
|